|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(2S)-2-[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorobenzoyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
8279 | plevitrexed |
Synonyms ![]() |
ZD 9331 | ZD-9331 | ZD9331 |
Database Links ![]() |
|
CAS Registry No. | 153537-73-6 |
ChEMBL Ligand | CHEMBL126648 |
GtoPdb PubChem SID | 252166490 |
PubChem CID | 213022 |
Search Google for chemical match using the InChIKey | IEJSCSAMMLUINT-NRFANRHFSA-N |
Search Google for chemicals with the same backbone | IEJSCSAMMLUINT |
Search PubMed clinical trials | plevitrexed |
Search PubMed titles | plevitrexed |
Search PubMed titles/abstracts | plevitrexed |
Search UniChem for chemical match using the InChIKey | IEJSCSAMMLUINT-NRFANRHFSA-N |
Search UniChem for chemicals with the same backbone | IEJSCSAMMLUINT |
Comments |
Plevitrexed is an orally bioavailable, small molecule, antifolate quinazoline derivative inhibitor of thymidylate synthetase with potential antineoplastic activity [1]. |